Skip to Main Content

Advertisement

Skip Nav Destination

Generic Drug Industry Dynamics

The Review of Economics and Statistics (2005) 87 (1): 37–49.
This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.
  • Matthew J. Higgins
  • Xin Yan
  • Chirantan Chatterjee
Research Policy (2021) 50 (1): 104126.
  • Hindustan Abdul Ahad
  • Haranath Chinthaginjala
  • Gangireddy Jayasimha Reddy
  • Pasupuleti Dheeraj Krishna
  • Syed Rahamathulla
  • Jyothi Vinay Krishna
Asian Journal of Research in Chemistry 331.
  • Colleen Cunningham
  • Florian Ederer
  • Song Ma
Journal of Political Economy (2021) 129 (3): 649.
  • Isabel Correia
  • Luís Armada
  • Paula Veiga
Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector (2021) 17 (1): 17.
  • Junghee Lee
  • Hyun Seok (Huck) Lee
  • Hyoduk Shin
  • Vish Krishnan
Management Science (2021) 67 (4): 2326.
  • Anton‐Giulio Manganelli
Health Economics (2021) 30 (1): 20.
  • Sachie Ono
  • Akira Komatsuzaki
  • Asami Iguchi
  • Hitomi Kikuchi
  • Shiho Motoi
  • Mio Susuga
International Journal of Environmental Research and Public Health (2021) 18 (21): 11329.
  • Difei Geng
  • Raja Kali
International Journal of Innovation Studies (2021) 5 (1): 23.
  • Victoria Serra-Sastre
  • Simona Bianchi
  • Jorge Mestre-Ferrandiz
  • Phill O’Neill
The European Journal of Health Economics (2021) 22 (2): 229.
  • César Portela
  • Vítor Fernandes
  • Paulo Cruz
British Journal of Healthcare Management (2020) 26 (8): 1.
  • Saranrat Wittayanukorn
  • Matthew Rosenberg
  • Andreas Schick
  • Meng Hu
  • Zhong Wang
  • Andrew Babiskin
  • Robert Lionberger
  • Liang Zhao
Therapeutic Innovation & Regulatory Science (2020) 54 (6): 1372.
  • Archita Sarmah
  • Domenico De Giovanni
  • Pietro De Giovanni
European Journal of Operational Research (2020) 282 (3): 1053.
  • Chung-Ying Lee
International Journal of Industrial Organization (2020) 70: 102611.
  • Atanu Saha
  • Heather Roberts
International Journal of the Economics of Business (2020) 27 (2): 159.
  • Ruben Jacobo-Rubio
  • John L. Turner
  • Jonathan W. Williams
The Journal of Law and Economics (2020) 63 (2): 203.
  • Andrew T. Ching
  • Manuel Ignacio Hermosilla
  • Qiang Liu
SSRN Electronic Journal (2019)
  • Xiaodong Guan
  • Haishaerjiang Wushouer
  • Mingchun Yang
  • Sheng Han
  • Luwen Shi
  • Dennis Ross-Degnan
  • Anita Katharina Wagner
BMJ Open (2019) 9 (11): e031658.
  • Anton-Giulio Manganelli
International Journal of the Economics of Business (2019) 26 (3): 411.
  • Ravi Gupta
  • Nilay D. Shah
  • Joseph S. Ross
Clinical Pharmacology & Therapeutics (2019) 105 (2): 329.
  • Russell Martin
  • Kavita Bahmani
Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector (2019) 15 (3): 115.
  • Yong Tan
Contemporary Economic Policy (2019) 37 (1): 86.
  • Elissa Philip Gentry
Journal of Risk and Uncertainty (2019) 58 (2-3): 219.
  • Imke Reimers
American Economic Journal: Microeconomics (2019) 11 (3): 257.
  • Melissa Newham
  • Jo Seldeslachts
  • Albert Banal Estaaol
SSRN Electronic Journal (2018)
  • Sharat Ganapati
  • Rebecca McKibbin
SSRN Electronic Journal (2018)
  • Geoffrey Joyce
  • Laura E. Henkhaus
  • Laura Gascue
  • Julie Zissimopoulos
Health Affairs (2018) 37 (10): 1578.
  • David Granlund
  • Mats A. Bergman
Journal of Health Economics (2018) 61: 1.
  • A. Ronald Gallant
  • Han Hong
  • Ahmed Khwaja
Management Science (2018) 64 (3): 1189.
  • Luke M. Olson
  • Brett W. Wendling
Review of Industrial Organization (2018) 53 (1): 139.
  • Simrun Grewal
  • Scott Ramsey
  • Sanjeev Balu
  • Josh J. Carlson
Expert Review of Pharmacoeconomics & Outcomes Research (2018) 18 (4): 447.
  • Michael S. Sinha
  • Mehdi Najafzadeh
  • Elizabeth K. Rajasingh
  • James Love
  • Aaron S. Kesselheim
JAMA Internal Medicine (2018) 178 (11): 1458.
  • Fiona M. Scott Morton
  • Ariel Dora Stern
  • Scott Stern
Review of Industrial Organization (2018) 53 (1): 173.
  • Mats A. Bergman
  • David Granlund
  • Niklas Rudholm
Oxford Bulletin of Economics and Statistics (2017) 79 (6): 969.
  • Elissa Philip Gentry
SSRN Electronic Journal (2017)
  • Olivier J. Wouters
  • Panos G. Kanavos
BMC Health Services Research (2017) 17 (1)
  • Wei Zhang
  • Huiying Sun
  • Daphne Guh
  • Aslam H. Anis
Expert Review of Pharmacoeconomics & Outcomes Research (2017) 17 (2): 231.
  • Ruben Jacobo-Rubio
  • John L. Turner
  • Jonathan W. Williams
SSRN Electronic Journal (2017)
  • Terence C. Burnham
  • Samuel Huang
  • Andrew W. Lo
SSRN Electronic Journal (2017)
  • Bastian Rake
Journal of Evolutionary Economics (2017) 27 (4): 691.
  • Leemore Dafny
  • Christopher Ody
  • Matt Schmitt
American Economic Journal: Economic Policy (2017) 9 (2): 91.
  • Virginia Acha
  • Jorge Mestre-Ferrandiz
Technology Analysis & Strategic Management (2017) 29 (3): 263.
  • Imke Reimers
SSRN Electronic Journal (2017)
  • Junjie Liu
  • Liming Wang
  • Chenxi Liu
  • Xinping Zhang
Expert Review of Pharmacoeconomics & Outcomes Research (2017) 17 (6): 625.
  • Nathaniel Refalo
  • Daniel Chetcuti
  • Amy Tanti
  • Anthony Serracino-Inglott
  • John Joseph Borg
Saudi Pharmaceutical Journal (2017) 25 (2): 280.
  • William V. Padula
  • Richard A. Larson
  • Stacie B. Dusetzina
  • Jane F. Apperley
  • Rudiger Hehlmann
  • Michele Baccarani
  • Ekkehard Eigendorff
  • Joelle Guilhot
  • Francois Guilhot
  • Rudiger Hehlmann
  • Francois-Xavier Mahon
  • Giovanni Martinelli
  • Jiri Mayer
  • Martin C. Müller
  • Dietger Niederwieser
  • Susanne Saussele
  • Charles A. Schiffer
  • Richard T. Silver
  • Bengt Simonsson
  • Rena M. Conti
Journal of the National Cancer Institute (2016) 108 (7): djw003.
  • Lee Branstetter
  • Chirantan Chatterjee
  • Matthew J. Higgins
The RAND Journal of Economics (2016) 47 (4): 857.
Close Modal

or Create an Account

Close Modal
Close Modal